Viridian Therapeutics, Inc./DE Other Income and Expense
Viridian Therapeutics, Inc./DE (VRDN) reported Other Income and Expense of -$851.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for the quarter ending 2026-06-30 was -$851.00K, a 114.11% decline year-over-year.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for the quarter ending 2026-03-31 was $11.27M, a 62.04% increase year-over-year.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for the quarter ending 2025-12-31 was $2.39M, a 69.10% decline year-over-year.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for the quarter ending 2025-09-30 was $5.41M, a 20.28% decline year-over-year.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for fiscal 2025 was $20.79M, a 28.51% decline from fiscal 2024.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for fiscal 2024 was $29.09M, a 74.00% increase from fiscal 2023.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for fiscal 2023 was $16.72M, a 277.34% increase from fiscal 2022.
- Viridian Therapeutics, Inc./DE nonoperating income (expense) for fiscal 2022 was $4.43M, a 1306.35% increase from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$851.00K 10-Q · filed 2026-08-06 | $10.42M 10-Q · filed 2026-08-06 | $12.81M derived: sum of 3 quarters · filed 2026-08-06 | $18.23M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $11.27M 10-Q · filed 2026-05-05 | $13.66M derived: sum of 2 quarters · filed 2026-05-05 | $19.08M derived: sum of 3 quarters · filed 2026-05-05 | $25.11M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.81M derived: sum of 2 quarters · filed 2026-02-26 | $13.84M derived: sum of 3 quarters · filed 2026-08-06 | $20.79M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $5.41M 10-Q · filed 2025-11-05 | $11.45M derived: sum of 2 quarters · filed 2026-08-06 | $18.40M 10-Q · filed 2025-11-05 | $26.15M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $6.03M 10-Q · filed 2026-08-06 | $12.99M 10-Q · filed 2026-08-06 | $20.73M derived: sum of 3 quarters · filed 2026-08-06 | $27.52M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $6.95M 10-Q · filed 2026-05-05 | $14.70M derived: sum of 2 quarters · filed 2026-05-05 | $21.49M derived: sum of 3 quarters · filed 2026-05-05 | $28.69M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.54M derived: sum of 2 quarters · filed 2026-02-26 | $21.73M derived: sum of 3 quarters · filed 2026-02-26 | $29.09M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $6.79M 10-Q · filed 2025-11-05 | $13.98M derived: sum of 2 quarters · filed 2025-11-05 | $21.34M 10-Q · filed 2025-11-05 | $25.96M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $7.19M 10-Q · filed 2025-08-06 | $14.55M 10-Q · filed 2025-08-06 | $19.17M derived: sum of 3 quarters · filed 2026-02-26 | $22.73M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $7.36M 10-Q · filed 2025-05-06 | $11.97M derived: sum of 2 quarters · filed 2026-02-26 | $15.54M derived: sum of 3 quarters · filed 2026-02-26 | $19.75M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.18M derived: sum of 2 quarters · filed 2026-02-26 | $12.39M derived: sum of 3 quarters · filed 2026-02-26 | $16.72M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $3.56M 10-Q · filed 2024-11-12 | $7.78M derived: sum of 2 quarters · filed 2024-11-12 | $12.10M 10-Q · filed 2024-11-12 | $15.38M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $4.21M 10-Q · filed 2024-08-08 | $8.53M 10-Q · filed 2024-08-08 | $11.81M derived: sum of 3 quarters · filed 2025-03-03 | $12.70M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $4.32M 10-Q · filed 2024-05-08 | $7.60M derived: sum of 2 quarters · filed 2025-03-03 | $8.48M derived: sum of 3 quarters · filed 2025-03-03 | $8.56M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $4.16M derived: sum of 2 quarters · filed 2025-03-03 | $4.23M derived: sum of 3 quarters · filed 2025-03-03 | $4.43M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $880.00K 10-Q · filed 2023-11-13 | $953.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.15M 10-Q · filed 2023-11-13 | $1.28M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-08 | $269.00K 10-Q · filed 2023-08-08 | $404.00K derived: sum of 3 quarters · filed 2024-02-27 | $495.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $196.00K 10-Q · filed 2023-05-10 | $331.00K derived: sum of 2 quarters · filed 2024-02-27 | $422.00K derived: sum of 3 quarters · filed 2024-02-27 | $456.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $226.00K derived: sum of 2 quarters · filed 2024-02-27 | $260.00K derived: sum of 3 quarters · filed 2024-02-27 | $315.00K 10-K · filed 2024-02-27 | $318.00K 10-K · filed 2022-03-11 |
| 2021-09-30 | $91.00K 10-Q · filed 2022-11-14 | $125.00K derived: sum of 2 quarters · filed 2022-11-14 | $180.00K 10-Q · filed 2022-11-14 | $216.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $34.00K 10-Q · filed 2022-08-15 | $89.00K 10-Q · filed 2022-08-15 | $125.00K derived: sum of 3 quarters · filed 2022-08-15 | $134.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $55.00K 10-Q · filed 2022-05-13 | $91.00K derived: sum of 2 quarters · filed 2022-05-13 | $100.00K derived: sum of 3 quarters · filed 2022-05-13 | $133.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $45.00K derived: sum of 2 quarters · filed 2022-03-11 | $78.00K derived: sum of 3 quarters · filed 2022-03-11 | $173.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-05 | $42.00K derived: sum of 2 quarters · filed 2021-11-05 | $137.00K 10-Q · filed 2021-11-05 | $260.00K derived: sum of 4 quarters · filed 2021-11-05 | |
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-12 | $128.00K 10-Q · filed 2021-08-12 | $251.00K derived: sum of 3 quarters · filed 2021-08-12 | $455.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $95.00K 10-Q · filed 2021-05-07 | $218.00K derived: sum of 2 quarters · filed 2021-05-07 | $422.00K derived: sum of 3 quarters · filed 2021-05-07 | $697.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $327.00K derived: sum of 2 quarters · filed 2021-03-26 | $602.00K derived: sum of 3 quarters · filed 2021-03-26 | $941.00K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $204.00K 10-Q · filed 2020-11-12 | $479.00K derived: sum of 2 quarters · filed 2020-11-12 | $818.00K 10-Q · filed 2020-11-12 | $1.18M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $275.00K 10-Q · filed 2020-08-05 | $614.00K 10-Q · filed 2020-08-05 | $978.00K derived: sum of 3 quarters · filed 2020-08-05 | $1.34M derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | $339.00K 10-Q · filed 2020-05-08 | $703.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.06M derived: sum of 3 quarters · filed 2020-05-08 | $1.43M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $726.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.09M derived: sum of 3 quarters · filed 2020-03-13 | $1.25M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $362.00K 10-Q · filed 2019-11-08 | $723.00K derived: sum of 2 quarters · filed 2019-11-08 | $890.00K 10-Q · filed 2019-11-08 | $1.05M derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | $361.00K 10-Q · filed 2019-08-08 | $528.00K 10-Q · filed 2019-08-08 | $686.00K derived: sum of 3 quarters · filed 2019-08-08 | $799.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | $167.00K 10-Q · filed 2019-05-09 | $325.00K derived: sum of 2 quarters · filed 2019-05-09 | $438.00K derived: sum of 3 quarters · filed 2019-05-09 | $540.00K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $271.00K derived: sum of 2 quarters · filed 2019-03-14 | $373.00K derived: sum of 3 quarters · filed 2019-03-14 | $403.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $113.00K 10-Q · filed 2018-11-07 | $215.00K derived: sum of 2 quarters · filed 2018-11-07 | $245.00K 10-Q · filed 2018-11-07 | $261.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | $102.00K 10-Q · filed 2018-08-08 | $132.00K 10-Q · filed 2018-08-08 | $148.00K derived: sum of 3 quarters · filed 2018-08-08 | $155.00K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $30.00K 10-Q · filed 2018-05-09 | $46.00K derived: sum of 2 quarters · filed 2018-05-09 | $53.00K derived: sum of 3 quarters · filed 2018-05-09 | $62.00K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $23.00K derived: sum of 2 quarters · filed 2018-03-15 | $32.00K derived: sum of 3 quarters · filed 2018-03-15 | $39.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $7.00K 10-Q · filed 2017-11-09 | $16.00K derived: sum of 2 quarters · filed 2017-11-09 | $23.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $9.00K 10-Q · filed 2017-08-11 | $16.00K 10-Q · filed 2017-08-11 | |||
| 2016-03-31 | $7.00K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |